Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
Cancers
|
June 19, 2024
Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis
Nishita Tripathi, Georges Gebrael, Beverly Chigarira, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
April 1, 2026
Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab
Georges Gebrael, Yeonjung Jo, Zeynep Irem Ozay, et al.
Molecular Cancer Therapeutics
|
October 11, 2018
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i>-Mutated Advanced Urothelial Carcinoma
Sumati Gupta, Daniel J Albertson, Timothy J Parnell, et al.
Urologic Oncology
|
August 2, 2022
Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma
Nishita Tripathi, Yeonjung Jo, Abhishek Tripathi, et al.
JAMA Network Open
|
July 18, 2024
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers
Chadi Hage Chehade, Yeonjung Jo, Georges Gebrael, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2020
Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer
Neeraj Agarwal, Roberto Nussenzveig, Andrew W Hahn, et al.
BMC Cancer
|
April 18, 2024
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial
Adriana M Coletta, Lea Haverbeck Simon, Kelsey Maslana, et al.
JAMA Network Open
|
May 2, 2024
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US
Vinay Mathew Thomas, Yeonjung Jo, Nishita Tripathi, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2023
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
Rom Leidner, Kevin Conlon, Douglas G McNeel, et al.
Clinical Genitourinary Cancer
|
October 5, 2017
Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System
Sumati Gupta, Daniel Albertson, David Gaston, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
Cancers
|
June 19, 2024
Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis
Nishita Tripathi, Georges Gebrael, Beverly Chigarira, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
April 1, 2026
Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab
Georges Gebrael, Yeonjung Jo, Zeynep Irem Ozay, et al.
Molecular Cancer Therapeutics
|
October 11, 2018
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i>-Mutated Advanced Urothelial Carcinoma
Sumati Gupta, Daniel J Albertson, Timothy J Parnell, et al.
Urologic Oncology
|
August 2, 2022
Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma
Nishita Tripathi, Yeonjung Jo, Abhishek Tripathi, et al.
JAMA Network Open
|
July 18, 2024
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers
Chadi Hage Chehade, Yeonjung Jo, Georges Gebrael, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2020
Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer
Neeraj Agarwal, Roberto Nussenzveig, Andrew W Hahn, et al.
BMC Cancer
|
April 18, 2024
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial
Adriana M Coletta, Lea Haverbeck Simon, Kelsey Maslana, et al.
JAMA Network Open
|
May 2, 2024
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US
Vinay Mathew Thomas, Yeonjung Jo, Nishita Tripathi, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2023
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
Rom Leidner, Kevin Conlon, Douglas G McNeel, et al.
Clinical Genitourinary Cancer
|
October 5, 2017
Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System
Sumati Gupta, Daniel Albertson, David Gaston, et al.
Page
of 7